Amyloid-β <sup>11</sup> C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Enchi Liu(University of Washington), Arthur Spirling, Stephen Salloway(Providence College), Lawrence S. Honig(Columbia University), Andrea Years, H. Robert Brashear(Janssen (United States)), Christian Schindler(Swiss Tropical and Public Health Institute), Bradley T. Wyman(Janssen (Belgium)), Michael Grundman(University of San Diego), S Broome, Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Chester A. Mathis(University of Pittsburgh), Anton P. Porsteinsson(University of Rochester), Peter Collins(Janssen (Belgium)), William E. Klunk(University of Pittsburgh), Celine Olivia(Brigham and Women's Hospital), Kevin Booth(Janssen (Belgium)), Eric Yuen(Janssen (United States)), Iulia Cristina Tudor(Janssen (United States)), Andrea S. Les(Janssen (Belgium)), Anthony Rosenzweig(University of Michigan), Murray A. Raskind(University of Washington), Lynne Harris(Brigham and Women's Hospital), Ronald Klein(University of Wisconsin–Madison), Mark E. Schmidt(Janssen (Belgium)), Richard Margolin, Daniel R. Rhodes(Howard Hughes Medical Institute), Robert A. Koeppe(University of Michigan), David Weisman(Brigham and Women's Hospital), N. Scott Mason(Janssen (Belgium)), Steven E. Arnold(University of Pennsylvania), Özkan Yalkinoglu(Brigham and Women's Hospital), Betty Diamond(Feinstein Institute for Medical Research), J. Wurziger(Brigham and Women's Hospital), A. Casher, V. Boruta(Brigham and Women's Hospital), Yuan Lü(Jazz Pharmaceuticals (United States)), David Hill(Guy's Hospital), Marwan N. Sabbagh(Cleveland Clinic), Martina Kirsch(Brigham and Women's Hospital), A Blue-Schaller, Jianing Di(Janssen (Belgium)), Keith M. Gregg(Janssen (United States)), Reisa A. Sperling(Brigham and Women's Hospital), James McGowan(Brigham and Women's Hospital), Steven H. Ferris(NYU Langone Health)
Neurology
July 25, 2015
Cited by 152


Related Papers